InvestorsHub Logo
Followers 41
Posts 1956
Boards Moderated 0
Alias Born 03/24/2014

Re: Pyrrhonian post# 63281

Monday, 05/30/2016 11:19:50 AM

Monday, May 30, 2016 11:19:50 AM

Post# of 706937
As stated, the average cost currently going from clinical trial phase all the way thru to approval and commercialization is $2.6 Billion. Your projection of cost per patient in a PH III trial is merely a small sliver of the cost to run and trial and ramp it up to market approval.

I wonder how they come up with that staggering $2.6 Billion #? Your #'s must reflect only what you want them to reflect and not what reality is.

The current vicious cycle on these boards are created by the constant guesses, speculations, deceptive information, overt pumping etc...
I'm certain you would agree that we should simply let this play out and wait for the data to speak for itself?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News